HSDT
Helius Medical Technologies, Inc. [HSDT] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
HSDT Stock Summary
Top 10 Correlated ETFs
HSDT
Top 10 Correlated Stocks
HSDT
In the News
HSDT Financial details
Company Rating
-
Market Cap
5.47M
Income
-7.43M
Revenue
644K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
22
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
-0.38
Forward P/E
-
PEG
0.05
P/S
6.95
P/B
1.72
P/C
-
P/FCF
-0.52
Quick Ratio
4.99
Current Ratio
5.98
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-11.79
EPS next Y
-
EPS next Q
-
EPS this Y
-68.7%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-15.51%
Revenue Q/Q
-6.29%
EPS Q/Q
-73.22%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-153%
ROE
-249%
ROC
-1.73%
Gross Margin
19%
Oper. Margin
-1623%
Profit Margin
-1715%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
4.29-14.45
52W High
-84.04%
52W Low
-44.13%
RSI
57
Rel Volume
0.42
Avg Volume
417.25K
Volume
176.36K
Perf Week
6.94%
Perf Month
31.47%
Perf Quarter
9.56%
Perf Half Y
-21.02%
-
-
-
-
Beta
1.553
-
-
Volatility
0.08%, 0.25%
Prev Close
3.95%
Price
2.235
Change
5.92%
Company Profile
- Volume Average 417.25K
- Market Capitalization 5.47M
- Employee 22
- CEO Mr. Dane Carl Andreeff
- Headquarters Newtown,PA,US
- IPO Date 2014-06-27
-
Website
https://heliusmedical.com 
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
